These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21804520)

  • 1. Alendronate induced femur fracture complicated with secondary hyperparathyroidism.
    Jain SK; Roy SP; Nagi ON
    Mymensingh Med J; 2011 Jul; 20(3):501-6. PubMed ID: 21804520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
    Cross MB; Nam D; van der Meulen MC; Bostrom MP
    J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
    Capeci CM; Tejwani NC
    J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
    Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
    Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous bilateral atypical femoral fractures after alendronate therapy.
    Zafeiris CP; Stathopoulos IP; Kourkoumelis G; Gkikas E; Lyritis GP
    J Musculoskelet Neuronal Interact; 2012 Dec; 12(4):262-4. PubMed ID: 23196269
    [No Abstract]   [Full Text] [Related]  

  • 6. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.
    Gomberg SJ; Wustrack RL; Napoli N; Arnaud CD; Black DM
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1627-32. PubMed ID: 21430030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.
    Goh SK; Yang KY; Koh JS; Wong MK; Chua SY; Chua DT; Howe TS
    J Bone Joint Surg Br; 2007 Mar; 89(3):349-53. PubMed ID: 17356148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fracture after long-term alendronate treatment: report of a case evidenced with magnetic resonance imaging.
    Kao CM; Huang PJ; Chen CH; Chen SJ; Cheng YM
    Kaohsiung J Med Sci; 2012 Oct; 28(10):555-8. PubMed ID: 23089322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
    Lee JK
    Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
    Ng YH; Gino PD; Lingaraj K; Das De S
    Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-energy femoral shaft fractures associated with alendronate use.
    Neviaser AS; Lane JM; Lenart BA; Edobor-Osula F; Lorich DG
    J Orthop Trauma; 2008; 22(5):346-50. PubMed ID: 18448990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
    Kwek EB; Goh SK; Koh JS; Png MA; Howe TS
    Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.
    Atik OS; Suluova F; Görmeli G; Yildirim A; Ali AKh
    Eklem Hastalik Cerrahisi; 2010 Apr; 21(1):56-9. PubMed ID: 20302562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic fractures associated with long-term bisphosphonate therapy - case report.
    Patel V; Graves L; Lukert B
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):251-4. PubMed ID: 23728112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases.
    Ballas EG; Mavrogenis AF; Karamanis E; Kokkalis ZT; Mitsiokapa E; Koulalis D; Mastrokalos D; Papagelopoulos PJ
    Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):181-7. PubMed ID: 24676887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
    Goddard MS; Reid KR; Johnston JC; Khanuja HS
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
    Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.